Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-600
Closed -$158K 193
2022
Q4
$158K Buy
+600
New +$161K 0.02% 193
2019
Q3
Sell
-600
Closed -$111K 195
2019
Q2
$111K Buy
+600
New +$107K 0.01% 212
2019
Q1
Sell
-600
Closed -$117K 197
2018
Q4
$117K Buy
+600
New +$117K 0.01% 217
2016
Q4
Sell
-4,503
Closed -$751K 228
2016
Q3
$751K Hold
4,503
0.05% 209
2016
Q2
$685K Hold
4,503
0.05% 211
2016
Q1
$675K Hold
4,503
0.05% 206
2015
Q4
$731K Buy
+4,503
New +$708K 0.06% 196
2015
Q3
Sell
-4,503
Closed -$691K 209
2015
Q2
$691K Hold
4,503
0.06% 200
2015
Q1
$720K Hold
4,503
0.06% 199
2014
Q4
$717K Buy
4,503
+40
+0.9% +$6.23K 0.06% 199
2014
Q3
$627K Hold
4,463
0.06% 198
2014
Q2
$528K Hold
4,463
0.05% 191
2014
Q1
$550K Buy
4,463
+119
+3% +$14.4K 0.05% 184
2013
Q4
$496K Hold
4,344
0.05% 189
2013
Q3
$486K Buy
4,344
+600
+16% +$65.1K 0.05% 192
2013
Q2
$369K Buy
+3,744
New +$389K 0.04% 207

Other funds holding AMGN

Phocas Financial Corp's AMGN Position: Q1 2023 in Review

Phocas Financial Corp sold out of Amgen (AMGN) in Q1 2023, closing a stake of 600 shares — an estimated $158K sold.

Phocas Financial Corp first reported a position in AMGN in Q2 2013 and held it in 16 quarters. The position peaked at $751K in Q3 2016. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Phocas Financial Corp reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Phocas Financial Corp sold 600 Amgen shares in Q1 2023, an estimated $158K.
  • Phocas Financial Corp first reported a position in Amgen in Q2 2013 and held it in 16 quarters.
  • Phocas Financial Corp's Amgen position peaked at $751K in Q3 2016.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Phocas Financial Corp's 13F filing for Q1 2023, filed 13 Apr 2023.